Abbott Laboratories Gets U.S. Subpoena on Bile-Duct Stents

NEW YORK, July 25 (Reuters) - Abbott Laboratories said on Friday that it received a subpoena last month from the U.S. Department of Justice related to the sales and marketing of its bile-duct stents.
MORE ON THIS TOPIC